Peer-influenced content. Sources you trust. No registration required. This is HCN.

Multiple Sclerosis News TodayMS News Notes: Dalfampridine, Neural Sleeve, Vitamin D

Unraveling the Complexities of MS: Dalfampridine Side Effects, Neural Sleeve Innovation, and the Vitamin D Connection

This review from columnist and MS patient Ed Tobias looks into three distinct facets of multiple sclerosis (MS) management and research: the real-world side effects of dalfampridine, the innovative Neural Sleeve, and the correlation between vitamin D levels and cognitive function in MS patients. These findings underscore the multifaceted nature of MS and highlight the need for personalized, comprehensive care strategies.

Key Points

  • Dalfampridine, also known as the “walking drug,” may cause side effects such as urinary tract infection, dizziness, and MS worsening. Unreported adverse events like spinal cord injury were also identified.
  • The Neural Sleeve, an AI-powered bionic clothing product, has been recognized as a Time ‘best invention.’ It aids walking in MS patients and others with foot drop.
  • A study found that low vitamin D levels in the blood are associated with poorer cognition and greater disability in MS patients. More than 39% of the patients in the study were found to be vitamin D deficient.

According to the National MS Society, nearly 1 million people are living with MS in the United States.

More on MS

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form